🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
That anti-TNF therapy and rituximab therapy are equally effective in treati...
Status
Completed
Location
NHS Fife
Start Date
2010-04
Trial ID
NCT01021735
Treatments Being Tested
This is a randomized, open-label, multi-center, phase 2 study of RCHOP with...
Status
Completed
Location
Tower Cancer Research Foundation
Start Date
2009-10
Trial ID
NCT00931918
Treatments Being Tested
B-cell Lymphoma is an aggressive and rare cancer of a type of immune cell (...
Status
Active Not Recruiting
Location
The University of Arizona Cancer Center - North Campus /ID# 242219
Start Date
2022-06-14
Trial ID
NCT05283720
Most of patients with autoimmune encephalitis are left with permanent cogni...
Status
Completed
Location
The First Affiliated Hospital, Zhejiang University
Start Date
2017-04-07
Trial ID
NCT03530462
Treatments Being Tested
The purpose is to identify a dose of SB-485232 which is safe, tolerable and...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-07-31
Trial ID
NCT00500058
One of the possible options for the treatment of MS at present is a high-do...
Status
Recruiting
Location
First Pavlov State Medical University of St. Petersburg
Start Date
2020-10-01
Trial ID
NCT05832515
Treatments Being Tested
This study aims to evaluate the safety, feasibility, and preliminary effica...
Status
Not Yet Recruiting
Location
Institute of Hematology & Blood Diseases Hospital, China
Start Date
2026-08-01
Trial ID
NCT07757685
Treatments Being Tested
This is an open label clinical study: Phase Ia is a dose escalation phase, ...
Status
Recruiting
Location
The First Affiliated Hospital, School of Medicine, Zhejiang University
Start Date
2025-07-01
Trial ID
NCT07073833
Treatments Being Tested
This phase II trial studies how well a dose adjusted regimen consisting of ...
Status
Completed
Location
M D Anderson Cancer Center
Start Date
2015-01-14
Trial ID
NCT02199184
This is a multicenter, randomized, double-blind, parallel group study to co...
Status
Terminated
Location
First Hospital of Shanxi Medical University
Start Date
2018-11-16
Trial ID
NCT03670888